SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-009841
Filing Date
2022-01-14
Accepted
2022-01-14 16:01:58
Documents
14
Period of Report
2022-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d293997d8k.htm   iXBRL 8-K 28802
2 EX-10.4 d293997dex104.htm EX-10.4 6612
6 GRAPHIC g293997g0114094828639.jpg GRAPHIC 3286
  Complete submission text file 0001193125-22-009841.txt   168766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20220112.xsd EX-101.SCH 2897
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20220112_lab.xml EX-101.LAB 18839
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20220112_pre.xml EX-101.PRE 11842
8 EXTRACTED XBRL INSTANCE DOCUMENT d293997d8k_htm.xml XML 3568
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 22531886
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences